Chad Hamilton to Granulocyte-Macrophage Colony-Stimulating Factor
This is a "connection" page, showing publications Chad Hamilton has written about Granulocyte-Macrophage Colony-Stimulating Factor.
Connection Strength
0.184
-
Interim analysis of a phase I/IIa trial assessing E39+GM-CSF, a folate binding protein vaccine, to prevent recurrence in ovarian and endometrial cancer patients. Oncotarget. 2017 Feb 28; 8(9):15912-15923.
Score: 0.142
-
Final analysis of a phase I/IIa trial of the folate-binding protein-derived E39 peptide vaccine to prevent recurrence in ovarian and endometrial cancer patients. Cancer Med. 2019 08; 8(10):4678-4687.
Score: 0.042